Welcome to CMEZone

CMEZone.com is a full-service web solution that provides timely, practical, and clinically relevant continuing education for health care professionals. All CMEZone activities are designed to enhance clinical knowledge and competence and to improve patient care.

More than 100,000 health care professionals maintain membership in CMEZone in order to access continuing education activities on demand. All activities are easily accessible, free of charge and offer participants instantaneous post-test grading and printable certificates of completion.

CMEZone is operated by Applied Clinical Education (ACE). As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens performance and enhances the clinical care of patients.

Participant Login


Remember Me
Lost your password? New user? Register here

Jointly sponsored by Global Education Group and Applied Clinical Education

GEGLogo CMEZoneLogo

Supported by an educational grant from

CovidenLogo

The REMEDIES Coalition also includes

ASPELogo iMDLogo MedMatrxLogo NAMCPLogo REALCMELogo


Las Vegas—The 2010 market withdrawal of an abuse-deterrent morphine product and the January 2013 FDA draft guidance on the evaluation and labeling of abus... To avoid administering codeine to ultra-rapid metabolizers—individuals whose livers convert codeine to morphine so quickly the reaction can be fatal—... In February, a panel of two FDA advisory committees voted 16-9 against asserting that naproxen has a lower risk for cardiovascular (CV) thrombotic events than o... More than 14% of pregnant women in a recent study received an opioid prescription for pain at some point during their pregnancy. The study results, posted in th... The FDA approved the first prescription treatment specifically designed for use by family members o San Diego—Early treatment with methotrexate plus a biologic therapy achieved sustained clinically inactive disease (CID) status in children with juvenile ...